These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial structure and function and its implications for current and emerging treatments for atrial fibrillation. Prabhu S; McLellan AJ; Walters TE; Sharma M; Voskoboinik A; Kistler PM Prog Cardiovasc Dis; 2015; 58(2):152-67. PubMed ID: 26247494 [TBL] [Abstract][Full Text] [Related]
4. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation. Rahmutula D; Zhang H; Wilson EE; Olgin JE Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604 [TBL] [Abstract][Full Text] [Related]
7. Three-dimensional Integrated Functional, Structural, and Computational Mapping to Define the Structural "Fingerprints" of Heart-Specific Atrial Fibrillation Drivers in Human Heart Ex Vivo. Zhao J; Hansen BJ; Wang Y; Csepe TA; Sul LV; Tang A; Yuan Y; Li N; Bratasz A; Powell KA; Kilic A; Mohler PJ; Janssen PML; Weiss R; Simonetti OP; Hummel JD; Fedorov VV J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862969 [TBL] [Abstract][Full Text] [Related]
8. Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case-control study of patients with history of atrial fibrillation. Mitrofanova LB; Orshanskaya V; Ho SY; Platonov PG Europace; 2016 Dec; 18(suppl 4):iv156-iv162. PubMed ID: 28011843 [TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation and heart failure-associated remodeling of two-pore-domain potassium (K Wiedmann F; Schulte JS; Gomes B; Zafeiriou MP; Ratte A; Rathjens F; Fehrmann E; Scholz B; Voigt N; Müller FU; Thomas D; Katus HA; Schmidt C Basic Res Cardiol; 2018 Jun; 113(4):27. PubMed ID: 29881975 [TBL] [Abstract][Full Text] [Related]
10. Aging Modulates the Substrate and Triggers Remodeling in Atrial Fibrillation. Lin YK; Chen YA; Lee TI; Chen YC; Chen SA; Chen YJ Circ J; 2018 Apr; 82(5):1237-1244. PubMed ID: 28904308 [TBL] [Abstract][Full Text] [Related]
11. Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps. Xintarakou A; Tzeis S; Psarras S; Asvestas D; Vardas P Europace; 2020 Mar; 22(3):342-351. PubMed ID: 31998939 [TBL] [Abstract][Full Text] [Related]
12. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1. Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370 [TBL] [Abstract][Full Text] [Related]
13. The expression profile analysis of atrial mRNA in rats with atrial fibrillation: the role of IGF1 in atrial fibrosis. Wang J; Li Z; Du J; Li J; Zhang Y; Liu J; Hou Y BMC Cardiovasc Disord; 2019 Feb; 19(1):40. PubMed ID: 30770724 [TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 Deficiency Induces Atrial Fibrosis and Increases Susceptibility to Atrial Fibrillation by the STAT3 Signaling Pathway. Zhang M; Wang H; Bie M; Wang X; Lu K; Xiao H J Cardiovasc Pharmacol; 2021 Aug; 78(2):175-183. PubMed ID: 34554674 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Bird's-Eye View of Left Atrial Myocardial Fibrosis in 121 Patients With Persistent Atrial Fibrillation: Developing Architecture and Main Cellular Players. Callegari S; Macchi E; Monaco R; Magnani L; Tafuni A; Croci S; Nicastro M; Garrapa V; Banchini A; Becchi G; Corradini E; Goldoni M; Rocchio F; Sala R; Benussi S; Ferrara D; Alfieri O; Corradi D Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e007588. PubMed ID: 32538131 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329 [TBL] [Abstract][Full Text] [Related]
18. Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation. Li LY; Lou Q; Liu GZ; Lv JC; Yun FX; Li TK; Yang W; Zhao HY; Zhang L; Bai N; Zhan CC; Yu J; Zang YX; Li WM Eur J Pharmacol; 2020 Aug; 881():173120. PubMed ID: 32325147 [TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of Paroxysmal and Persistent Atrial Fibrillation: Rotors, Foci and Fibrosis. Lau DH; Linz D; Schotten U; Mahajan R; Sanders P; Kalman JM Heart Lung Circ; 2017 Sep; 26(9):887-893. PubMed ID: 28610723 [TBL] [Abstract][Full Text] [Related]
20. Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation. Liu Y; Niu XH; Yin X; Liu YJ; Han C; Yang J; Huang X; Yu X; Gao L; Yang YZ; Xia YL; Li HH J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]